Collectively, our data suggest that HMGCS1 upregulation is positively correlated with activation of the MAPK pathway in AML RR patients and HMGCS1 activates MAPK pathway in AML cell lines. The gene discussed is HMGCS1; the disease is acute myeloid leukemia.